Endocare And Galil Relations Cold As Prostate Cryosurgery Market Heats Up
This article was originally published in The Gray Sheet
Executive Summary
The number of cryoablation procedures to treat prostate cancer is expected to grow more than 100% over the next year, fueled by favorable outcomes from a five-year study evaluating Endocare's Cryocare system, the company predicts.